Robert Sidonio: Prophylaxis with Wilate and The WIL-31 Study Results
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Congrats to my co-authors and Octapharma on this wonderful paper focused on the results of type 3 VWD and prophylaxis with Wilate.”
Title: Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL-31 Study Sub-Analysis
Authors: Claudia Djambas Khayat, Leonid Dubey, Adlette Inati, Toshko Lissitchkov, Dzmitry Novik, Elina Peteva, Robert F. Sidonio Jr, Ali T. Taher, Kateryna V. Vilchevska, Vladimir Vdovin, Ana Boban
Read the Full Article on European Journal of Haematology
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 3, 2026, 13:21Pete Stibbs: From Scientific Ideas to Clinical Impact
-
Nov 3, 2026, 13:06Backflow-Induced Clot Formation During Red Cell Transfusion – AABB
-
Nov 3, 2026, 12:38Kemal Karaagac: DOACs vs. VKAs in Cerebral Venous Thrombosis
-
Nov 3, 2026, 12:30Pakeeza Arshad: RDW and Bone Marrow Recovery in Hematological Malignancies
-
Nov 3, 2026, 12:21Mohamed Touhid Patel: Combining Microfluidics and SERS for Advanced Blood Analysis
-
Nov 3, 2026, 12:17Renata Vernay Lopes: Advancing Patient Blood Management and Care at HEMO 2026
-
Nov 3, 2026, 12:13Ashna Sadadiwala: Addressing Oral Health Challenges in People With Haemophilia
-
Nov 3, 2026, 11:53Marcello Miltersteiner: Advancing Hematology Through Innovation at HEMO 2026
-
Nov 3, 2026, 02:21Digambar Panchal: NGS Demonstrates Key Role in Solving Challenging Hematology Cases at LTMGH